Extraordinary advances are happening at the Mount Sinai Health System, and we want you to be among the first to know. Mount Sinai Physician’s Channel will show you some of the innovative procedures, developments in patient care, and complex cases that are being handled in our world-class facilities. We invite you to come back often to stay on top of what’s new in your specific field.
Featured Content
New Content |view more
A team from the Icahn School of Medicine at Mount Sinai has developed the most comprehensive epidemiological dataset for youth diabetes and prediabetes research, derived from extensive National Health and Nutrition Examination Survey (NHANES) ...
Endocrinology, Diabetes, and Bone Disease 2024
The Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Icahn School of Medicine at Mount Sinai is dedicated to advancing the understanding and treatment of diabetes, obesity, conditions affecting ...
The outstanding faculty in the Division of Endocrinology, Diabetes and Bone Disease continue to make innovative advances in translational research and clinical care. Core to those missions is training the next generation of leaders in our field.
Endocrinology Fellowship, the Largest in U.S., Excels in Clinical and Research Training
The merger of Mount Sinai’s Endocrinology fellowships into a systemwide, five-hospital program has proved successful in its first two years, with the 14 fellows gaining a wide variety of experience in research and clinical care.
Mount Sinai Team Identifies Regions of DNA Associated With Excess Testosterone in PCOS
A team led by Andrea Dunaif, MD, has identified regions of DNA associated with testosterone production in women with polycystic ovary syndrome, bringing the field a step closer to determining the molecular causes of the condition.
Mount Sinai Endocrinologists Expand Diabetes Technology Use
Carol J. Levy, MD, and her team are working to expand the use of automated insulin delivery technology—studying its use in insulin-requiring people with type 2 diabetes and during pregnancies complicated by type 1 diabetes.
Diabetes, Obesity and Metabolism Institute Makes Strides in Basic and Translational Science
The Diabetes, Obesity and Metabolism Institute made further outstanding progress in 2023 in the study of diabetes, obesity, and metabolic syndromes. The Institute continued its pioneering research in beta cell regeneration and a rising ...
The increasing use of biologic agents for chronic treatment of Crohn’s disease and ulcerative colitis has meant that corticosteroids are typically reserved for use during flares. The intermittent use of these efficacious therapies has ...
A team led by Prashant Rajbhandari, PhD, discovered a family of molecules in the breast called “mammokines” that contribute not only to normal mammary biology, but to overall fat cell physiology and energy balance control.
Diabetes May Accelerate Multiple Myeloma Growth, With Survival Outcomes Worse Among White Patients
Patients with multiple myeloma who also have diabetes have reduced overall survival when compared to those without diabetes. However, in a subgroup analysis, this difference in survival due to diabetes was seen in white patients but not in Black patients.
Mount Sinai Study Finds Testosterone Use in Transmasculine People Is Safer Than Previously Reported
Testosterone treatment for gender-affirming hormone therapy in transmasculine individuals often conjures up safety concerns among prescribing physicians, and patients and their families. However, the largest study of its type to date found ...
Mount Sinai researchers have made breakthrough discoveries about the thyroid-stimulating hormone receptor that suggest new approaches to the treatment of autoimmune thyroid disease.